Background
oesophageal cancers
INTESTINAL METAPLASIA, OESOPHAGEAL CANCER
Around 9200 oesophageal cancers are diagnosed in the UK every year [The Cytosponge is a non-endoscopic cell-collection device, which, coupled with a laboratory test for the biomarker trefoil factor 3 (TFF3), can be used to diagnose intestinal metaplasia, which is a hallmark of Barrett’s oesophagus [Good patient experience is a key aspect of providing high-quality medical care and is associated with higher levels of adherence to recommended prevention and treatment plans, and better clinical effectiveness and outcomes [Although patient experience was good overall in the BEST3 trial, some participants reported negative experiences of some aspects of the procedure, particularly in relation to the swallowing and retrieval of the device [